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ABSTRACT 
The Escherichia coli soxRS regulon activates oxidative 
stress and antibiotic resistance genes in two transcrip- 
tional stages. SoxR protein becomes activated in cells 
exposed to excess superoxide or nitric oxide and then 
stimulates transcription of the soxS gene, whose 
product in turn activates 10 regulon promoters. 
Purified SoxR protein is a homodimer containing a pair 
of [2Fe-2S] centers essential for soxS transcription 
in vitro. The [2Fe-2S] centers are thought to be 
anchored by a C-terminal cluster of four cysteine 
residues in SoxR. Here we analyze mutant SoxR 
derivatives with individual cysteines replaced by 
alanine residues (CysAla). The mutant proteins in 
cell-free extracts bound the soxS promoter with 
wild-type affinity, but upon purification lacked Fe or 
detectable transcriptional activity for soxS in vitro. 
Electron paramagnetic resonance measurements in vivo 
indicated that the CysAla proteins lacked the [2Fe-
2S] centers seen for wild-type SoxR. The CysAla 
mutant proteins failed to activate soxS expression 
in vivo in response to paraquat, a superoxide- generating 
agent. However, when expressed to 5% of the cell 
protein, the CysAla derivatives increased basal soxS 
transcription 2–4-fold. Overexpression of the 
Cys119Ala mutant protein strongly interfered with 
soxS activation by wild-type SoxR in response to 
paraquat. These studies demonstrate the essential 
role of the [2Fe-2S] centers for SoxR activation in vivo; 
the data may also indicate oxidant-independent mech- 
anisms of transcriptional activation by SoxR. 
 
INTRODUCTION 
Bacteria regulate many genes in response to imbalances in the 
production and disposal of reactive oxygen species; such 
conditions are often called ‘oxidative stress’ (1). In Escherichia 
coli, a set of 12 dispersed promoters under the control of the 
soxRS locus is activated when cells are exposed to sublethal levels 
of compounds, such as paraquat (PQ) (2,3), which generate 
intracellular superoxide, or to nitric oxide (4,5). This soxRS 
regulon controls antioxidant functions [e.g. superoxide dismutase 
or glucose-6-phosphate dehydrogenase (1)], repair of oxidative 
DNA damage [endonuclease IV (1)] and antibiotic resistance 
genes [micF (6) or acrAB (7)]. The soxRS system may also 
provide resistance to the toxicity of organic solvents and some 
heavy metals (8). The soxRS regulon is switched on in two 
transcriptional stages: existing SoxR protein is activated by an 
intracellular redox signal and triggers transcription of the soxS 
gene; the resulting SoxS protein binds and activates transcription 
from the various regulon promoters (1). 
SoxR protein is the master regulator of the soxRS response 
(9,10). SoxR in vitro binds and strongly stimulates transcription 
of the soxS promoter by the exponential-phase RNA polymerase 
(RNAP) containing the 70 protein (11). The activity of SoxR as 
a transcription factor is completely dependent on the presence of 
non-heme iron in the protein (11). The metal is present in the 
active homodimeric SoxR protein as a pair of [2Fe-2S] clusters, 
which are in the oxidized form when the protein is isolated from 
cells (12,13). SoxR activity can be regulated either by the 
assembly and disassembly of its iron–sulfur clusters (14,15) or by 
oxidation–reduction of the [2Fe-2S] centers, with the oxidized 
protein being the transcriptionally active form in vitro (16,17). 
Recent in vivo experiments support the interpretation that reduced 
SoxR is transcriptionally inactive (18). 
From the foregoing it is clear that the [2Fe-2S] centers in SoxR 
are intimately involved in the protein’s function as a transcription 
regulator in vitro, but their in vivo importance has not been 
validated. Attempts to control iron availability are complicated by 
the essential roles of Fe in other proteins, and by the complex 
regulation governing the assimilation and storage of this metal 
(19). Initial spectroscopic analysis indicates that each [2Fe-2S] 
center in SoxR is anchored by four thiol ligands, which accounts 
for the four cysteine residues present in each protein monomer 
(12,13). In this work we have tested the biological role of the 
[2Fe-2S] centers by mutating the individual cysteine residues of 
SoxR. These mutations eliminate the activation of SoxR by 
oxidative stress in vivo and prevent the assembly of stable 
iron–sulfur centers in the protein, but still allow a significant level 
of basal SoxR activity when the mutant proteins are expressed at 
high levels. 
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MATERIALS AND METHODS 
Strains and plasmids 
This work employed the E.coli K-12 strains carrying single copy 
operon fusions present in lysogenized phage : strain TN521, a 
derivative of GC4468 (2) but soxRS::zjc2205-kan (soxR+ 
soxS::lacZ) (20); and strain TN5311, as TN521 except 
(soxR soxS::lacZ) (20) and containing F proAB lacIq 
lacZM15::Tn10 (21), transferred from XL1-blue (Stratagene, 
La Jolla, CA) by conjugation. The pBluescript plasmid was from 
Stratagene and does not contain an inducible promoter for 
recombinant gene expression. The plasmid pSE380 contains the 
lacIq gene and the lac repressor-regulated trc promoter for 
controlled expression of recombinant genes (Invitrogen, San 
Diego, CA). The plasmid pKEN2 [a generous gift of G. Verdine, 
Harvard University (11)] contains a lac-regulated derivative of 
the tac promoter for controlled expression of recombinant genes 
but does not contain its own lacI gene; expression from 
pKEN2-derived plasmids is regulated by chromosomal lacI. 
 
Construction of cysteine-to-alanine mutations 
Four mutant soxR genes, each encoding an alanine residue 
substituting for a SoxR cysteine (residues 119, 122, 124 and 130), 
were constructed by using a plasmid containing the soxRS locus 
[pBD100; (22)] as a template for sequential rounds of polymerase 
chain reaction (PCR). For the first round of amplification, primers 
T3 (5-ATTAACCCTCACTAAAG-3) and T7 (5-AATAC- 
GACTCACTATAG-3), specific for sequences in the 
pBluescript KS vector were used together with mutagenic 
primers converting the cysteine codon (TGT or TGC) to an 
alanine codon (GCT or GCC; underlined below). 
a) C119A 5-GAACTGGACGGAGCTATTGGTTGTGG-3 
b) C119A 5-CCACAACCAATAGCTCCGTCCAGTTC-3 
c) C122A 5-GATGTATTGGTGCTGGCTGCCTTT-3 
d) C122A 5-AAAGGCAGCCAGCACCAATACATC-3 
e) C124A 5-TGCGCGAAAGGGCGCCACAACCAA-3 
f) C124A 5-TTGGTTGTGGCGCCCTTTCGCGCA-3 
g) C130A 5-CAGTGATGCCCCGTTGCGTA-3 
h) C130A 5-TACGCAACGGGGCATCACTG-3 
Overlapping PCR products were generated using the pairs of 
primers, pBD100 (10 ng) as the template, and 1 U cloned Pfu 
DNA polymerase (Stratagene) and isolated from the reaction 
mixtures using a commercially available spin column (Qiagen, 
Chatsworth, CA). Approximately 10 ng of each pair of overlapping 
soxR fragments were then combined with 50 pmol of the T3 and 
T7 primers in a 100 l reaction mixture. After denaturation and 
reannealing of the overlapping complementary cysteine coding 
regions, PCR yielded fragments (728 bp) containing the full-length 
mutated genes. These were purified and digested with EcoRI and 
HindIII (New England Biolabs, Beverley, MA), electrophoresed 
in a 1% agarose gel in Tris-acetate/EDTA buffer (23) and 
recovered from gel slices using DEAE membranes (Schleicher 
and Schuell, Keene, NH). The purified fragments were subcloned 
into EcoRI/HindIII-digested pBluescript and transformed into 
XL1-Blue cells. Transformants were selected on LB agar plates 
(21) containing 75 g/ml ampicillin, 15 g/ml tetracycline and 
the LacZ+ indicator 5-bromo-4-chloro-3-indolyl--D-galacto- 
pyranoside (21). White colonies were selected and analyzed by 
PCR using the T3 and T7 primers to verify the presence of 
full-length soxR in the plasmids. Plasmid DNA was purified from 
positive clones and both strands of the soxR inserts completely 
sequenced by the dideoxy chain termination method (23) using 
Sequenase II (US Biochemical) and the following primers: T3, T7, 
SRKR (5-GGGCAACACGCCAAACGCT-3), SRKF (5-
AGC- GTTTGGCGTCTTGCCC-3), E4 (5-
GCGCGGATCCCAGC- GGCGATATAAA-3) and E5K (5-
GCGCGAGCTCGCTTTCG- TCCCAATGG-3). 
The four mutant cysteine sequences were subcloned from the 
pBluescript vectors into pKEN2, generating the plasmids 
pKENC119A,  pKENC122A,  pKENC124A  and pKEN130A. 
The C119A mutant gene was also subcloned into pSE380 to 
generate pSEC119A for subsequent studies. Despite several 
attempts, stable insertion of the other cysteine mutant genes into 
pSE380 was unsuccessful. 
 
Preparation of whole cell homogenates and partially 
purified protein 
Plasmids derived from pKEN2 were transformed into E.coli strain 
TN5311 and grown in 200 ml LB broth (21) containing 75 g/ml 
ampicillin, 15 g/ml streptomycin and 15 g/ml kanamycin to 
OD600  0.5–1. Isopropyl--D-thio-galactopyranoside (IPTG) 
was then added to a final concentration of
0 
0.5 mM, and the 
incubation was continued for 120 min at 3
0
7   C. The cells were 
harvested by centrifugation at 10 000 g at 4 C, resuspended and 
washed three times with ice-cold M9 salts (21). The final cell 
pellet was resuspended to a volume of 1.0 ml with 50 mM 
HEPES–NaOH, pH 7.6, 0.1 M NaCl, and lysed by agitation with 
glass beads (400 l beads/ml) in a Mini-bead beater (Biospec 
Products, Bartlesville, OH
0
) for 3 min. Following centrifugation 
at 10 000 g fo
0
r 45 min a
0
t 4  C, the supernatants were collected and 
frozen at –20 C or –80 C until assay. Cell extracts were resolved 
on 15% SDS–polyacrylamide gels (24) and stained with Coomassie 
blue as previously described (11). 
SoxR mutant proteins were also extensively purified using 
DE52–Sepharose and heparin–agarose column chromatography 
as described previously (11). 
Iron and protein determinations 
The Fe content of partially purified SoxR proteins (11) was 
determined by inductively coupled plasma emission spectrometry at 
the Chemical Analysis Laboratory, Institute of Ecology, University 
of Georgia (Athens, GA). SoxR concentrations were estimated by 
scanning densitometry analysis (Visage System, Millipore, 
Milford, MA) of Coomassie blue-stained SoxR in SDS–polyacryl- 
amide gels (24) using a SoxR standard previously quantified by 
amino acid analysis. 
 
DNA–protein binding 
The binding affinity of wild-type and mutant SoxR proteins for 
the soxS promoter in vitro was analyzed by electrophoretic 
mobility shift assays, as previously described (9,11). 
 
Preparation of cell suspensions 
TN5311 transformed with the expression plasmid pKEN2 or its 
soxR-containing derivatives pKOXR [containing the wild-type 
soxR gene; (22)], pKENC119A, pKENC122A, pKENC124A or 
pKENC130A were grown overnight in LB broth containing 
ampicillin (100 g/ml). A fresh 125-ml aliquot of the same 
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Figure 1. Location of [2Fe-2S] cluster and cysteine replacements in SoxR protein. 
 
medium was in
0
oculated with 1.25 ml of overnight culture and 
incubated at 37 C with shaking at 250 r.p.m. for 110 min. IPTG 
was added to a f
0
inal concentration of 0.5 mM, and the incubation 
continued at 37 C with shaking for an additional 120 min. The 
cells were harvested by centrifugation and resuspended in 0.5 ml 
of 50 mM HEPES–NaOH, pH 7.6, 0.1 M NaCl. Freshly dissolved 
dithionite, 0.1 M dithionite in 1 M HEPES–NaOH pH 7.6, was 
then added to the cell paste to a final concentration of 1 mM. 
Aliquots (300–400 l cell paste) were immediately placed inside 
4 m
0
m EPR sample tubes, frozen in liquid nitrogen and kept at 
–80  C until analysis. The total SoxR concentration in the cells 
was determined by Western blot analysis of samples lysed 
directly in sample buffer (24), using previously quantified SoxR 
as a standard. 
 
Immunological methods 
Wild-type E.coli SoxR protein was purified to near homogeneity 
as described previously (11). The purified protein was emulsified 
in complete Freund’s adjuvant and injected subcutaneously into 
two New Zealand black rabbits. Starting three weeks after the 
primary injection, the rabbits received booster injections every 2 
weeks with similar SoxR preparations in incomplete Freund’s 
adjuvant. Polyclonal antisera were extracted periodically starting 
4 weeks after the first injection, and SoxR-specific antibodies 
were enriched by affinity chromatography using SoxR-columns 
generated by coupling purified SoxR protein to HiTrap NHS- 
activated columns (Pharmacia) according to the conditions 
recommended by the supplier. Polyclonal serum was applied to 
the columns and SoxR-specific antibodies eluted following 
standard procedures (25). 
For immunoblotting, samples of cell suspensions or purified 
SoxR were electrophoresed in SDS–polyacrylamide gels, and 
transferred to nitrocellulose membranes (Schleicher and Schuell, 
Keene, NH) with a TE series Transphor electrophoresis unit 
(Hoefer Scientific, San Francisco, CA). The filters were probed with 
the affinity-purified antisera and bound antibody was detected 
with alkaline phosphatase-conjugated anti-rabbit IgG antibodies 
(Promega, Madison, WI). 
 
EPR spectroscopy 
X-band EPR spectra were recorded at 20 K on a Bruker model 
ESP300 spectrometer maintained at constant temperature, with 
an Oxford Instruments model ESR910 continuous flow cryostat 
as described previously (14,15). The amount of reduced SoxR 
was determined by comparison in the same experiment to 
standardized Fe-SoxR samples after reduction with dithionite 
 
 
(13,14). The high EPR background noise of the cell paste was 
greatly reduced by electronically subtracting from the spectra for 
SoxR-containing samples the spectrum of TN5311-pKEN2 cells, 
which do not express SoxR. 
In vitro transcription 
The activity of wild-type and mutant SoxR proteins was 
determined by in vitro transcription of the soxS gene by 
commercial E.coli RNA polymerase accompanied by the indicated 
amounts of SoxR, as described previously (13,14). 
 
-Galactosidase assays 
The ability of the mutant proteins to stimulate soxS transcription 
in vivo was assessed using TN521 and TN5311. TN5311 cells 
were transformed either with the pBluescript-based plasmids for 
low-level SoxR expression, or with the pKEN2-based plasmids 
for high-level expression. TN521 cells were also transformed 
with the pSEC119A plasmid. Overnight cultures of the indicated 
strains were diluted 1:100 (or in some experiments 1:1000) into 
fresh LB broth containing 50 g/ml ampicillin and treated as 
follows. For TN5311 containing pBluescript-based plasmids, PQ 
was added to a final concentration o
0
f 100 M to one aliquot at 
OD600  0.4, and incubation at 37 C continued 60 min. For 
TN5311 containing pKEN2-based plasmids, when the cell 
density approached OD600  0.1, IPTG was added to a final 
concentration of 0.5 mM and after 60 min PQ was added as above. 
For TN521 containing pSE380 or pSEC119A, IPTG was added 
(to 0.5 mM) at OD600  0.05. Aliquots of the cultures were 
removed at 0, 30 or 60 min following IPTG addition, PQ added 
(final concentration 250 M) and the incubation continued 30 min 
before harvesting for the assay. -Galactosidase activity was 
assayed in SDS/CHCl3-treated cells as described by Miller (21). 
RESULTS 
Both strands of the four soxR CysAla mutant genes were 
sequenced to verify the presence of the mutant codons. Each of 
the four mutant alleles contained the desired mutations 
(TGTGCT or TGCGCC) (Fig. 1) that reprogrammed the 
cysteine codon to an alanine codon. The full-length sequences of 
the four mutant constructs showed that no additional mutations 
were introduced by the site-specific procedure. 
In vitro properties of SoxR CysAla mutant proteins 
SoxR proteins for in vitro characterization were overexpressed in 
TN5311 cells (soxRS) transformed with pKEN2-derived 
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Figure 2. (A) Coomassie blue-stained SDS–polyacrylamide gel of protein 
extracts from TN5311 cells overexpressing wild-type and mutant SoxR 
proteins. SoxR, 1 or 0.5 g purified wild-type SoxR protein. Cell extracts (15g): 
WT, pKOXR plasmid; –, pKEN2 plasmid; C1, pKENC119A plasmid; C2, 
pKENC122A plasmid; C3, pKENC124A plasmid; C4, pKENC130A plasmid. 
, the electrophoretic position of purified SoxR. (B) Binding activity for soxS 
promoter DNA SoxR-containing cell extracts. Lane 1, DNA alone; lane 2, 
vector control (5 g); lanes 3 and 4, wild-type SoxR extract (WT); lanes 5 and 6, 
SoxR-C119A extract (C1); lanes 7 and 8, SoxR-C122A extract (C2); lane 9 or 
10, SoxR-C124A extract (C3); lanes 11 and 12, SoxR-C130A extract (C4); odd 
numbered lanes correspond to 0.5 g extract protein, even numbered lanes to 
5 g. C, SoxR–DNA complex; D, free DNA. 
 
 
vectors encoding either wild-type SoxR (pKOXR) or the 
respective mutant proteins encoded by pKENC119A, 
pKENC122A, pKENC124A and pKENC130A. SDS–PAGE 
analysis of cell extracts demonstrated the presence of similar 
amounts of the wild-type and the four cysteine mutant proteins, 
each with Mr = 17 000 (identical to that of wild-type SoxR; Fig. 2A). 
We sought to determine whether elimination of the cysteine 
residues might impair the ability of the mutant proteins to bind 
soxS promoter DNA in vitro in electrophoretic mobility shift 
assays (EMSA) (11). Cell-free extracts containing wild-type and 
mutant SoxR proteins displayed similar levels of soxS binding 
activity in vitro that increased with the amount of extract protein 
added (Fig. 2B). The mutant and wild-type proteins therefore 
bind the soxS target with similar affinities, since the proteins were 
present at similar levels in the extracts (Fig. 2A). 
Since the CysAla mutant SoxR proteins retained DNA 
binding activity, all four proteins were extensively purified  (to 
90% homogeneity), in parallel with wild-type SoxR and in 
similar yield (data not shown). The purified mutant proteins each 
lacked the visible absorbance characteristic of oxidized Fe-SoxR 
and had no significant Fe detectable by inductively coupled 
plasma emission spectrometry (<0.1 atom Fe per SoxR monomer; 
data not shown). It seemed possible that the CysAla mutant 
proteins might contain iron in vivo, but lose the metal during 
purification. Analysis by EPR spectroscopy of intact cells 
overexpressing the various proteins showed that all the CysAla 
 
mutants lacked the near-axial resonance spectrum characteristic 
of reduced wild-type Fe-SoxR (12–15), while such a spectrum 
was easily seen in cells overexpressing the wild-type protein (Fig.3). 
For the wild-type protein overexpressed in vivo in the absence of 
PQ treatment, 36% was detected as the reduced Fe-SoxR form, 
consistent with other experiments performed in a similar manner 
(18). 
From the foregoing results, there was no indication that the 
mutant proteins contained [2Fe-2S] centers in vivo, although the 
unlikely possibility remains that such centers are present but 
remain in an EPR-silent (oxidized?) state. In vitro transcription 
assays (14) showed that the CysAla mutant proteins were 
devoid of transcriptional activity for the soxS gene, and behaved 
similarly to apo-SoxR (Fig. 4). As found for the crude extracts 
(Fig. 2B), binding activity of the purified mutant proteins for the 
soxS promoter was indistinguishable from that of wild-type SoxR 
(data not shown). Thus, the CysAla mutant proteins neither 
have tightly bound [2Fe-2S] centers nor function as specific 
transcription factors for the soxS gene in vitro. 
 
In vivo properties of the CysAla mutant proteins 
In view of the lack of transcriptional activity of the mutated SoxR 
proteins in vitro, we wished to determine whether the CysAla 
mutant proteins retained ability to induce regulated expression of 
the soxS gene in vivo. For this purpose we used a soxRS strain 
harboring a single copy of the soxS::lacZ fusion (TN5311), in 
which expression of -galactosidase activity encoded by the 
fusion depends on the in vivo activity of SoxR expressed in trans 
(20,26). The in vivo effectiveness of the mutant SoxR proteins 
was initially examined using constructs in the pBluescript vector, 
which lacks a strong inducible promoter and expresses wild-type 
SoxR at a level similar to cells containing a single soxR+ allele in 
the genome (E.H. and B.D., unpublished data). All four mutant 
proteins failed to increase -galactosidase activity above the 
basal level observed with the vector alone, even when the 
cells were grown in the presence of PQ, which strongly 
activated soxS expression in cells with wild-type SoxR (14-
fold; Fig. 5A). 
The results were somewhat different when intracellular SoxR 
concentrations were elevated (to 5% of the total cell protein) 
using the high level expression vector pKEN2 (11,13) (see Fig. 2A 
for SoxR protein levels). Wild-type SoxR (expressed from this 
vector) yielded 19-fold soxS activation in response to PQ (Fig. 5B), 
giving an induced level of -galactosidase expression nearly 
twice that seen for cells bearing the wild-type pBluescript 
construct (Fig. 5A). Thus, the normal intracellular concentration 
of SoxR may be limiting for soxS activation in some situations. 
In contrast, cells overexpressing the mutant proteins from the 
pKEN2 vector exhibited elevated soxS expression that was not 
affected by PQ (Fig. 5B). For three of the mutant proteins 
(C119A, C122A and C124A) the level of soxS::lacZ 
expression was 4-fold higher than the basal (uninduced) 
expression mediated by wild-type SoxR; for the C130A 
protein, basal expression was 2-fold higher (Fig. 5B). The 
CysAla mutant proteins have therefore lost responsiveness to 
the redox signal generated by PQ, but can exert a higher basal 
transcriptional activity than wild-type SoxR. 
It seemed possible that expression of the mutant proteins might 
interfere with wild-type SoxR, either through the formation of 
heterodimers or by competition for binding the soxS promoter. At 
low levels of mutant SoxR expression (from the pBluescript 
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Figure 3. EPR analysis of SoxR in vivo. The EPR spectra of cell suspensions were recorded as described previously for purified Fe-SoxR (13). The intracellular SoxR 
concentration [SoxR] was estimated by immunoblotting of whole cell extracts (see Materials and Methods). The content of reduced [2Fe-2S] SoxR in the cells was 
estimated from the amplitude of the EPR resonance at gy (15) normalized to a known preparation of purified SoxR. 
 
 
 
 
Figure 4. SoxR-dependent in vitro transcription of soxS. Fe-SoxR (active), 
apo-SoxR (inactive) or CysAla mutant proteins (5 ng each) were incubated 
with 100 nM RNAP in in vitro transcription reactions containing a plasmid 
carrying both the SoxR-dependent soxS gene and the SoxR-independent bla 
gene as indicated in Materials and Methods. The corresponding primer 
extension reactions (13,14) for the soxS and bla transcripts are indicated. 
 
 
vectors), induction of soxS by wild-type SoxR in response to PQ 
was unaffected (data not shown). 
An additional study was conducted to assess the effect of 
overexpressing one of the mutant proteins (C119A) on the 
inducibility of soxS in TN521 (soxR+) cells. Because this strain 
harbors only the lacI+ allele, we used the vector pSE380 (bearing 
lacIq; see Materials and Methods) to achieve tightly regulated 
SoxR expression inducible by IPTG. After 1000-fold dilution of 
overnight cultures into fresh medium and outgrowth for 60 min, 
IPTG was added, followed at various times by a 30 min exposure 
to PQ (250 M) to measure activation of soxS transcription. The 
induction of soxS::lacZ by PQ was essentially the same for 
both the vector control (pSE380) and the strain 
overexpressing wild-type SoxR (from pSXR) throughout the 
course of the experiment (Fig. 6). In contrast, the expression 
of the C119A protein strongly interfered with soxS induction, 
even at the earliest time point (some leaky expression of SoxR 
is expected even in the absence of IPTG). PQ inducibility was 
completely eliminated after only a 30 min pre-induction of the 
mutant protein with IPTG (Fig. 6). As seen in Figure 5B, basal 
expression of 
 
-galactosidase from soxS::lacZ was increased to 1000 U 
in cells overexpressing the C119A protein. 
 
DISCUSSION 
Our previous work established that the SoxR [2Fe-2S] centers are 
essential for the protein’s transcriptional activity at soxS in vitro 
(11,13–15). Here, we have extended the demonstration of this 
requirement to the activity of SoxR in vivo by engineering mutant 
genes that direct the synthesis of SoxR derivatives with individual 
cysteine residues replaced by alanines. For at least the C119A 
derivative, high level synthesis interfered with the normal activity 
of SoxR during activation by PQ. Despite their inability to be 
activated by oxidative stress, overexpression of the CysAla 
SoxR proteins revealed an unexpectedly high level of basal 
transcriptional activity in vivo that was not detected in vitro. 
Removal of the SoxR [2Fe-2S] clusters in vitro by aerobic 
exposure of the protein to 2-mercaptoethanol (11,13) or the 
biological thiol glutathione (15) eliminates the transcriptional 
activity at soxS without any apparent effect on SoxR protein 
stability, oligomeric state or binding affinity for the soxS 
promoter. Elimination of detectable metal binding by CysAla 
replacements effectively blocked SoxR activation in response to 
PQ and did not significantly affect protein expression in vivo or 
soxS binding in vitro. These observations provide new evidence 
for post-translational activation of SoxR, and show that this 
activation in vivo depends critically on the integrity of the 
[2Fe-2S] centers. The results also support the conclusion from 
EPR spectroscopy that all four SoxR cysteine residues are 
involved in anchoring the metal center. Efforts to assemble 
[2Fe-2S] centers into the Cys119Ala protein in vitro were 
unsuccessful (14). 
Re-insertion in vitro of [2Fe-2S] centers into wild-type apo-
SoxR restored full transcriptional activity (14). However, the 
properties of the CysAla mutant proteins alone do not resolve 
whether the critical step for SoxR activation in vivo is synthesis 
of the [2Fe-2S] centers or a subsequent redox reaction. We have 
previously suggested (13,14) that these two steps might be linked 
if the stability of the metal centers is influenced by oxidation and 
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Figure 5. Expression of soxS::lacZ as a function of mutant SoxR 
expression in strain TN5311 (soxR). (A) Low level expression via uninduced 
pBluescript vectors or (B) high level expression via induced pKEN2 vectors. 
+, incubation with PQ; –, non-exposed cells. -galactosidase activity is 
expressed as Miller units (21). 
 
 
reduction. However, recent experiments (16,17) indicate that 
SoxR with reduced [2Fe-2S] centers is stable, but transcriptionally 
inactive in vitro. In vivo studies of the properties of constitutive 
forms of SoxR extend this model to living cells (18). 
For wild-type SoxR, the quantity of reduced [2Fe-2S] centers 
detected in untreated cells corresponded to only 36% of the total 
SoxR protein (Fig. 3). The EPR-silent forms include both 
oxidized and apo-SoxR (12,13), with only the former active in 
vitro (11,16,17). The in vivo EPR analysis shown here and 
elsewhere (18) thus supports the conclusion that reduced Fe-
SoxR is transcriptionally inactive in cells. Some oxidation 
evidently occurs during sample preparation by the method 
employed here: using a modified method (H.D. and B.D., 
manuscript in preparation), we have measured levels of reduced 
wild-type protein representing 95% of the total SoxR. 
Two additional features of the SoxR CysAla mutants merit 
mention. First, during activation by PQ, none of the substituted 
forms, when expressed at approximately wild-type levels, 
competed detectably with wild-type SoxR expressed from a 
single-copy gene; such interference was observed only upon high 
level expression of the C119A derivative. In view of their 
evidently normal stability and DNA binding affinity, the relative 
 
 
 
Figure 6. Interference of SoxR-C119A protein with wild-type SoxR in vivo. 
The bottom lines indicate the plasmid present (pSE380, control; pSXR, wild-type 
SoxR; pSEC119, SoxR-C119A) in strain TN521 (soxR+ soxS::lacZ), the time 
of IPTG treatment to induce recombinant SoxR, and exposure to PQ (+). 
-Galactosidase activity is shown in units (21). All values represent the 
mean of three independent samples, except pSEC119/0 min/no PQ, for which 
only two samples were available. 
 
 
ineffectiveness of the mutant proteins in blocking soxS activation 
by wild-type SoxR is striking. In principle, the mutant proteins 
could interfere with wild-type SoxR in two ways: by the 
formation of mixed dimers with a wild-type subunit, or by 
competition for binding the soxS promoter. It would thus be of 
interest to determine whether the mixed dimers retain partial or 
complete function. Regarding the second possible mode of 
interference, wild-type SoxR and the CysAla mutant proteins 
bound the soxS promoter equally well in vitro (Fig. 2B). However, 
RNAP binds the soxS promoter cooperatively with activated 
SoxR (11), an effect that could disfavor competition by low levels 
of the CysAla mutant proteins. 
The second unexpected feature of the CysAla mutant forms 
of SoxR was the relatively high basal soxS transcription they exert 
upon overexpression in vivo, which contrasts with the essentially 
undetectable activity of these proteins in vitro. It remains possible 
that the CysAla mutant proteins cause transcriptional activa- 
tion higher than that of apo-SoxR, but at a level still undetectable 
in our in vitro assay. Alternatively, the in vivo activity of the 
mutant proteins in the absence of a redox signal could suggest the 
existence of additional controls on soxS activation that are overcome 
by high concentrations of the CysAla derivatives but not non-
activated wild-type SoxR. The known negative autoregulation by 
SoxS (27) is evidently not responsible for this effect, which we 
observed in SoxS deficient cells. Previous genetic studies (2,3) 
identified regulatory mutations only in soxR and soxS (9,10), but 
a smaller effect on soxS expression caused by other mutations 
might have been missed. One possible negative regulator is Rob 
protein, which is abundant [5000 molecules/cell; (28)] and has 
DNA binding specificity that overlaps that of SoxS (29–31). 
MarA protein also exhibits overlapping specificity with SoxS 
(32), but its expression is kept low through repression by the 
MarR protein (33). 
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